Market Overview

Acadia Up 14% After Q2 Beat


Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) shares are trading higher by $4.20 at $33.74 in Wednesday's session.

After the close on Tuesday, the company announced a Q2 EPS beat of 17 cents along with a $10 million beat for sales.

After a much higher open, Acadia had only a 15-cent retreat to $32.60 before continuing its move higher. So far, the ensuing rally has taken the stock to $34.95, but hasn't been able to hold that elevated level. That high coincides with its May 1 high of $34.98.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (ACAD)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

22 Biggest Mid-Day Losers For Wednesday

The US Relationship With Guam, Explained